Summary:
Neuroscientists at Northwestern University have identified a specific population of neurons that triggers acute anxiety when cannabinoids are consumed under stressful conditions. In a preclinical study published in Nature Communications, the team found that cannabinoids interfere with an inhibitory “brake” on somatostatin-expressing neurons in the central amygdala. When external threats are present, this disinhibition causes fear networks to become hyperactive, explaining how high-potency cannabis or an anxious environment can rapidly convert a relaxing high into acute paranoia or panic.
Key Facts:
- The Amygdala Anxiety Switch: In mice, synthetic cannabinoids increased fear responses and freezing by selectively activating somatostatin-expressing interneurons in the central amygdala.
- Releasing the Brake: Larger cannabinoid doses, together with environmental stressors, impair the brain’s natural inhibitory control over these neurons, allowing amygdala fear circuits to overactivate.
- Reversing the Anxiety: Genetically silencing central amygdala somatostatin neurons eliminated cannabinoid-induced threat avoidance, highlighting a potential therapeutic target for anxiety disorders.
Source: Northwestern University
Cannabis is widely used for its calming, euphoric, and stress-relieving effects. Yet clinicians and recreational users have long observed a paradox: in some people or at higher doses, cannabinoids can provoke severe anxiety, catastrophic thoughts, or panic attacks. These adverse reactions are particularly likely when cannabis is used in unpredictable, frightening, or otherwise stressful settings.
As high-potency THC products have become more widely available, emergency department visits related to cannabis-induced panic and psychotic-like episodes have increased. Although the role of CB1 cannabinoid receptors throughout the brain is well established, the cellular mechanism that determines whether cannabis soothes or aggravates anxiety has been unclear—until now.
Researchers at Northwestern University Feinberg School of Medicine report that cannabinoids disinhibit a small group of fear-processing cells—somatostatin (SOM) neurons—within the central amygdala (CeA). This disinhibition leaves the brain overly sensitive to perceived threats and can convert what begins as a pleasurable experience into a distressing one.
“The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis or the situation they are in turns stressful or scary,” said study senior author Sachin Patel, M.D., Ph.D., Chair of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine.
Tracking Threat Perception in the Living Brain
To model threat perception, the team exposed mice to a predator-associated odor (derived from fox urine) while administering either placebo or graded doses of a synthetic cannabinoid. Using miniature head-mounted fluorescent microscopes (miniscopes), they recorded calcium activity from individual neurons as the animals explored the arena.
Behaviorally, cannabinoid-treated mice froze more, avoided the scent more strongly, and spent far less time investigating than controls. Electrophysiological recordings in brain slices revealed the underlying circuit changes:
- Disruption of an inhibitory brake: Under baseline conditions, GABAergic inputs restrain somatostatin-positive CeA neurons, keeping them relatively quiet.
- Synergistic hyperactivation: Cannabinoids weaken that inhibitory control. When combined with a threatening cue, the lack of inhibition allows SOM neurons to fire excessively, amplifying defensive behavior.
“Higher doses of cannabinoids and environmental stress worked together to synergistically release the ‘brake’ on the central amygdala, which in turn drove excessive anxiety,” Dr. Patel explained.
Silencing the Circuit Restores Normal Behavior
To test causality, the researchers used chemogenetic and genetic techniques to selectively silence CeA somatostatin neurons. With these neurons turned off, mice given cannabinoids no longer displayed heightened freezing or extreme avoidance; they resumed normal exploration and investigation of the environment.
These findings demonstrate that central amygdala SOM neurons act as a direct gateway for cannabinoid-induced behavioral distress, rather than being merely correlated with it.
Clinical and Public Health Implications
The study has broad implications as cannabis potency rises and mood and anxiety disorders remain prevalent. Understanding the neural pathways by which cannabinoids can worsen anxiety could inform strategies to prevent or treat such adverse reactions.
Because the central amygdala coordinates fear, trauma responses, and autonomic distress, targeting this specific subpopulation of somatostatin neurons may offer a new approach for developing therapies for generalized anxiety disorder, panic disorder, and post-traumatic stress disorder (PTSD), beyond addressing cannabis-related side effects.
“Suppressing the activity of somatostatin neurons in the central amygdala could represent a final pathway for reducing anxiety symptoms, not just in the context of cannabis side effects,” Dr. Patel concluded.
Funding: Supported by the National Institutes of Health (grants MH100785 and K08 MH126166) and the Brain & Behavior Research Foundation’s Young Investigator Awards.
Editorial Notes:
- Edited by a Neuroscience News editor and reviewed against the full journal paper.
- Additional context added by editorial staff to clarify methods and implications.
About this Research
- Media Contact: Ben Schamisso
- Source: Northwestern University
- Image Credit: Image credited to Neuroscience News
- Original Research (Open Access): Nature Communications (Sept 22, 2026). Title: “Cannabinoid Modulation of Central Amygdala Population Dynamics During Threat Investigation.” Authors: Farhana Yasmin, Saptarnab Naskar, Danyal Zaidi, Isaac Kandil, Michelle Kwon, Luis E. Rosas-Vidal & Sachin Patel.
- DOI: 10.1038/s41467-026-77957-4
Abstract
Cannabinoid Modulation of Central Amygdala Population Dynamics During Threat Investigation
Cannabinoids can precipitate anxiety and panic in humans and increase threat-related defensive responses in rodents in a dose- and context-dependent manner. However, how cannabinoids alter in vivo neural dynamics associated with threat-related behavior has been unclear.
This study shows that cannabinoids dose-dependently boost threat-induced defensive behaviors and increase activity of CeA somatostatin neurons in mice. These neurons are required for cannabinoid-driven increases in threat avoidance, though not for freezing behavior itself. Cannabinoid treatment also enhanced the formation of behavior-linked neuronal subensembles and altered how location and action are represented in the CeA.
While cannabinoid receptor activation reduced excitatory inputs onto SOM neurons in ex vivo preparations, the data indicate a preferential suppression of local GABA release that disinhibits SOM neurons in vivo. Overall, these findings explain how cannabinoid-mediated presynaptic suppression can transform postsynaptic population dynamics and influence threat-related defensive responses.
